Total Return chart Aprogen Biologics Inc.

Stocks

End-of-day quote Korea S.E. 2026-10-02			5-day change	1st Jan Change
1,564.00 ^KRW	+1.03%		-4.58%	-79.91%

09-22	Aprogen Biologics Inc. announced that it has received KRW 20.0000011 billion in funding from Aprogen Medicines Inc.	CI
09-02	Aprogen Biologics Inc. announced that it expects to receive KRW 20.0000011 billion in funding from Aprogen Medicines Inc.	CI

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.